Vor Biopharma VOR Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's other income (expense)?
- Vor Biopharma (VOR) reported other income (expense) of -$184.43M in Q1 2026.
- How has Vor Biopharma's other income (expense) changed year-over-year?
- Vor Biopharma's other income (expense) decreased by 23009.9% year-over-year, from $805K to -$184.43M.
- What is the long-term trend for Vor Biopharma's other income (expense)?
- Over 3 years (2021 to 2024), Vor Biopharma's other income (expense) has grown at a 229.9% compound annual growth rate (CAGR), from $119K to $4.27M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.